Wirkstoffe entwickeln

Which medicines and vaccines work best?

Controlled testing of new drugs and vaccines for tropical diseases

Novel interventions and medically active agents are urgently needed to combat and control epidemics and neglected diseases. The aim is therefore to expand clinical research and the necessary infrastructure at the BNITM and African partner institutions.

[Translate to English:] Grafi Arbeitsberich des BNITM
The development of drugs and vaccines - The BNITM is intensively involved in various phases of materials development, from basic research to the analysis of how drugs are optimally used.

To this end, a corresponding study centre will be established as a platform. Here, clinical research and studies with national and international partners will be carried out according to the highest quality standards. In this context, the BNITM plans to prioritise the expansion of research activities in the tropics. The scientific focus in this area will be on drug development and research on prevention of malaria and neglected tropical diseases. In addition, there will be a clinical research focus on tropical viral diseases. International research collaborations in the field of tropical and travel medicine will be intensified.

Travel medicine is becoming increasingly important against a background of increasing international travel, especially to tropical countries. Our goal is to establish the BNITM as a leading centre for the clinical development of evidence-based travel medicine interventions (vaccines, drugs, preventive measures). A professorship for travel medicine will therefore be established to further develop the profile.

Contact

  • Dr  Eleonora Schoenherr
  • Science Officer
  • phone: +49 40 285380-269
  • fax: +49 40 285380-265
  • email: schoenherr@bnitm.de
  • Dr.  Anneke Novak-Funk
  • Executive Assistant to the Board
  • phone: +49 40 285380-266
  • email: novak-funk@bnitm.de

Downloads